Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Comment by moneywagonon Feb 17, 2021 12:41pm
46 Views
Post# 32585454

RE:RE:AION THANK YOU!! DUZ YA WANNA GO LOWER?

RE:RE:AION THANK YOU!! DUZ YA WANNA GO LOWER?
InvestABCs wrote: What do you see as the catalyst for the next leg up?
New website, news on progress with any of the following newswires


Aion Therapeutic Inc C.AION

 

Aion Therapeutic Inc is engaged in the business of providing contract tolling extraction services to third-party businesses.
$0.125Bid: 0.12 x 43500Ask: 0.125 x 141000Volume: 218,555
CADCANADIAN SECURITIES
 

Aion Therapeutic Grants Stock Options; Announces Management Change

Newsfile 13 days ago

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Newsfile December 23, 2020

Aion Therapeutic Amends Convertible Debentures

Newsfile October 30, 2020

Aion Therapeutic Names James W.G. Thompson, Ph.D. as President

Newsfile October 21, 2020

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Newsfile September 18, 2020

Aion Therapeutic, Inc. Announces the Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas as Chief Science Officer

Newsfile September 10, 2020

Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

Newsfile September 3, 2020

Aion Therapeutic's Dr. Stephen D. Barnhill to Present at Microdose "Psychedelic Capital Series" on September 3, 2020

Newsfile August 31, 2020

<< Previous
Bullboard Posts
Next >>